The University of Bergen and the Kavli Institute at NTNU are joining forces on brain research with support from the Trond Mohn Foundation.
Kavli Institute for Systems Neuroscience
A tiny region in the middle of the brain plays a far more important role than previously known in helping it respond to changes in the environment, a new study shows.
Researchers at NTNU are studying brain cells in the lab to investigate the foggy beginnings of diseases like Parkinson’s and Alzheimer’s.
Nobel laureate and Kavli Institute for Systems Neuroscience founding director and professor Edvard Moser says a new technology “opens doors to experiments we could only dream about 5 years ago.” The technology in question is called Neuropixels 2.0, a new favourite in the neuroscientists’ toolbox.
The 2020 ISI/Web of Science Highly Cited Researchers list includes seven researchers affiliated with NTNU. The list includes authors who have multiple articles ranked in the top 1 per cent by citation in their field over the last decade.
Developing an effective treatment for Alzheimer’s disease is the long-term goal of a new national research centre in Norway. Nobel laureates Edvard Moser and May-Britt Moser will lead the K. G. Jebsen Centre for Alzheimer’s Disease, aimed at determining how Alzheimer’s disease arises in the brain and its early stages of development.
We create mental maps as we move around. But these maps can be distorted if the surroundings change. That makes it more difficult to remember where something was.
Researchers at NTNU’s Kavli Institute for Systems Neuroscience have found specialized brain cells that help us navigate in space.